Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 130,100
+3,700 (2.93%)
Feb 9, 2026, 3:30 PM KST
Medy-Tox Market Cap
Medy-Tox has a market cap or net worth of 887.3 billion as of February 6, 2026. Its market cap has increased by 6.68% in one year.
Market Cap
887.30B
Enterprise Value
907.54B
Revenue
241.80B
Ranking
n/a
PE Ratio
37.19
Stock Price
130,100.00
Market Cap Chart
Since January 16, 2009, Medy-Tox's market cap has increased from 71.73B to 887.30B, an increase of 1,137.07%. That is a compound annual growth rate of 15.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 887.30B | 4.64% |
| Dec 30, 2025 | 847.99B | 2.03% |
| Dec 30, 2024 | 831.10B | -48.75% |
| Dec 28, 2023 | 1.62T | 101.16% |
| Dec 29, 2022 | 806.18B | -7.99% |
| Dec 30, 2021 | 876.20B | -13.91% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 1.68T |
| MEDIPOST | 957.60B |
| GI Innovation | 839.93B |
| Pharmicell | 803.45B |
| Proteina | 790.92B |
| Onconic Therapeutics | 743.34B |
| Green Cross Holdings | 677.39B |
| Genomictree | 544.78B |